Spatial biology platform company SYNCELL announced that its founder, Dr. Jung-Chi Liao, has officially taking a leave from his Research Fellow position at Institute of Atomic and Molecular Sciences (IAMS) Academia Sinica to take the helm of SYNCELL as CEO.

Before joining IAMS in 2014, Dr. Liao had held a faculty position at Columbia University where he focused his research towards using super-resolution microscopy to understand primary cilia. While at IAMS, he continued to deploy super-resolution microscopy to study various biological problems. His own research need to harvest proteins and nucleic acids from a minute cellular structure motivated him to invent Microscoop, the world’s first pickable optoproteomics technology. He founded SYNCELL in 2020 to further the development of this powerful microscopy-based system that has broad applicability in cell biology and biomedical research.

“I want to advance this innovative technology into a breakthrough spatial biology solution,” Dr. Liao said. “Our imaging-based spatial proteomics system has overcome the technical limitation of requiring validated antibodies to study the expression of any protein panels.”

As the CEO of SYNCELL, Dr. Liao will provide leadership for Microscoop product development and commercialization to realize SYNCELL’s vision of becoming a dominant player in the spatial omics field. Dr. Liao holds a PhD degree from Massachusetts Institute of Technology and a BS degree in Mechanical Engineering from National Taiwan University.

About SYNCELL Inc.
SYNCELL is a development stage company with a vision to revolutionize in situ cell biology and biomedical research. The company will soon introduce its groundbreaking Microscoop™ platform, the first and only system that allows users to pick up, identify and quantify thousands of known and unknown proteins in specified cellular and subcellular locations. Microscoop™ is pairing unique imaging and illuminating capabilities with novel photolabeling chemicals to provide deep spatial proteomics insights to transform a wide range of basic biology and translational research including neuroscience, oncology, immunology, infectious disease, gene therapy, and to identify novel therapeutic targets with spatial context to accelerate drug discovery and development programs.

CONTACT:
Shuyi Liao
SYNCELL, Inc.
Phone +886-2-77505632
Info@syncell.com
Follow SYNCELL on LinkedIn at SYNCELL INC. and tag your posts with #syncell or #microscoop"